Sreenivasa Rao Kondapally Seshasai is the co-author of an article this month in The Lancet, the world’s leading platform for peer-reviewed publications in medical science. The article, of which a summary can be found here, considers whether a link exists between statin use and the development of diabetes. The study examines the results of statin trials with over 90,000 participants, and concludes that statin therapy is associated with only a slightly increased risk of the development of diabetes.
This is Rao’s second article in the journal within the last year, testifying to the quality of the work he is undertaking in the University’s Molecular Epidemiology Unit in south Cambridge.
